Form 4: FDBC CEO reports insider purchase; SARs disclosed
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Fidelity D & D Bancorp (FDBC) insider filing: the President & CEO, a director and officer, purchased 1,000 shares of common stock at $44.50 on 11/10/2025. Following the trade, direct beneficial ownership stands at 60,410.8589 shares.
The insider also holds 13,626 stock appreciation rights, all vested, from grants with exercise prices of $21.60, $26.17, $49.50, and $59.70, expiring on 2/1/2026, 2/6/2027, 2/5/2028, and 2/4/2029.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 1,000 shares ($44,500)
Net Buy
2 txns
Insider
SANTANIELLO DANIEL J
Role
President & CEO
Bought
1,000 shs ($45K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 1,000 | $44.50 | $45K |
| holding | stock Appreciation Rights | -- | -- | -- |
Holdings After Transaction:
Common Stock — 60,410.859 shares (Direct);
stock Appreciation Rights — 13,626 shares (Direct)
Footnotes (1)
- 2016 Grant = $21.60, 2017 Grant = $26.17, 2018 Grant = $49.50 and 2019 Grant = $59.70. All stock appreciation rights have vested. The stock appreciation rights expire as follows: 2/1/2026 for the 2016 grant, 2/6/2027 for the 2017 grant, 2/5/2028 for the 2018 grant and 2/4/2029 for the 2019 grant.
FAQ
What did FDBC’s insider report on Form 4?
The President & CEO purchased 1,000 FDBC common shares at $44.50 on 11/10/2025.
What derivative securities does the FDBC insider hold?
The insider holds 13,626 vested stock appreciation rights tied to common stock.
What are the exercise prices of the SAR grants?
The grants are priced at $21.60, $26.17, $49.50, and $59.70.
When do the SARs expire?
They expire on 2/1/2026, 2/6/2027, 2/5/2028, and 2/4/2029.
What is the insider’s role at FDBC?
The reporting person is a Director and the company’s President & CEO.